# Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis

> **NCT04064411** · PHASE3 · COMPLETED · sponsor: **Radius Health, Inc.** · enrollment: 511 (actual)

## Conditions studied

- Postmenopausal Osteoporosis

## Interventions

- **COMBINATION_PRODUCT:** abaloparatide
- **COMBINATION_PRODUCT:** abaloparatide solid microstructured transdermal system

## Key facts

- **NCT ID:** NCT04064411
- **Lead sponsor:** Radius Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-05
- **Primary completion:** 2021-10-05
- **Final completion:** 2021-11-09
- **Target enrollment:** 511 (ACTUAL)
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04064411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04064411, "Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04064411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*